Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Trials Related to Pancreatic Ductal Adenocarcinoma
Related studies linked through entity extraction aliases.
Escitalopram to Placebo in Patients With Localized Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Application of 68Ga-DOTA-NT-20.3 in the Early Diagnosis of Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- NA
Peri-operative SLOG for Localized Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers
- Status
- COMPLETED
- Phase
- PHASE2
AB122 Platform Study
- Status
- RECRUITING
- Phase
- PHASE1
Fecal Microbial Transplants for the Treatment of Pancreatic Cancer
- Status
- SUSPENDED
- Phase
- EARLY_PHASE1
Pancreatic Cancer Early Detection Consortium
- Status
- RECRUITING
- Phase
- N/A
Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Radiomics Based on Multimodal Imaging in Predicting Staging and Prognosis of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- N/A
Perioperative or Adjuvant mFOLFIRINOX for Resectable Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1